Abstract: Photodynamic therapy to prevent secondary cataracts is effected using photosensitizers such as green porphyrins as photoactive agents to destroy remnant lens epithelial cells.
Type:
Grant
Filed:
March 27, 2000
Date of Patent:
June 19, 2001
Assignees:
QLT, Inc., The University of British Columbia, Ciba Vision Opthalmics
Inventors:
Howard E. Meadows, Danielle Wenkstern, David R. Mallek, Marcello Nick Bussanich, Anna M. Richter, Julia G. Levy, Claude A. A. Hariton, Gustav Huber, Jack Rootman
Abstract: Photodynamic therapy to prevent secondary cataracts is effected using photosensitizers such as green porphyrins as photoactive agents to destroy remnant lens epithelial cells.
Type:
Grant
Filed:
December 10, 1996
Date of Patent:
March 28, 2000
Assignees:
QLT PhotoTherapeutics, Inc., The University of the British of Columbia, Ciba Vision Opthalmics
Inventors:
Howard E. Meadows, Danielle Wenkstern, David R. Mallek, Marcello Nick Bussanich, Anna M. Richter, Julia G. Levy, Claude A. A. Hariton, Gustav Huber, Jack Rootman